- Home
- FOX vs ONC Comparison
FOX vs ONC Comparison
Compare FOX & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOX
- ONC
- Stock Information
- Founded
- FOX 2018
- ONC 2010
- Country
- FOX United States
- ONC Switzerland
- Employees
- FOX N/A
- ONC N/A
- Industry
- FOX Broadcasting
- ONC Biotechnology: Pharmaceutical Preparations
- Sector
- FOX Industrials
- ONC Health Care
- Exchange
- FOX Nasdaq
- ONC Nasdaq
- Market Cap
- FOX 23.0B
- ONC 26.9B
- IPO Year
- FOX N/A
- ONC N/A
- Fundamental
- Price
- FOX $50.67
- ONC $255.42
- Analyst Decision
- FOX
- ONC Strong Buy
- Analyst Count
- FOX 0
- ONC 9
- Target Price
- FOX N/A
- ONC $325.56
- AVG Volume (30 Days)
- FOX 1.2M
- ONC 352.7K
- Earning Date
- FOX 08-05-2025
- ONC 08-06-2025
- Dividend Yield
- FOX 1.07%
- ONC N/A
- EPS Growth
- FOX 26.95
- ONC N/A
- EPS
- FOX 4.03
- ONC N/A
- Revenue
- FOX $16,105,000,000.00
- ONC $4,175,868,000.00
- Revenue This Year
- FOX $17.70
- ONC $869.15
- Revenue Next Year
- FOX N/A
- ONC $19.07
- P/E Ratio
- FOX $12.55
- ONC N/A
- Revenue Growth
- FOX 15.70
- ONC 51.16
- 52 Week Low
- FOX $32.06
- ONC $143.00
- 52 Week High
- FOX $55.00
- ONC $287.88
- Technical
- Relative Strength Index (RSI)
- FOX 49.91
- ONC N/A
- Support Level
- FOX $50.21
- ONC N/A
- Resistance Level
- FOX $53.58
- ONC N/A
- Average True Range (ATR)
- FOX 1.09
- ONC 0.00
- MACD
- FOX -0.15
- ONC 0.00
- Stochastic Oscillator
- FOX 27.34
- ONC 0.00
About FOX Fox Corporation Class B
Fox operates in two segments: cable networks and television. Cable networks primarily includes Fox News, Fox Business, and several pay-TV sports stations. Television primarily includes the Fox broadcast network, 29 owned and operated local television stations, of which 18 are affiliated with the Fox network, and streaming platform Tubi, which is not subscription-based and is completely ad-supported. Fox effectively sold most of its entertainment assets to Disney in 2019, so it no longer creates entertainment content and relies heavily on live news and sports, with nearly all tied to the pay-TV bundle. The Murdoch family controls Fox.
About ONC BeiGene Ltd. American Depositary Shares
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeiGene's revenue.